FIELD: pharmacology.
SUBSTANCE: invention relates to an antiseptic preparation in the form of a gel that contains chlorhexidine gluconate-0.01-0.5 g, methyl-4-hydroxybenzoate-0.01-0.1 g, ethyl 4-hydroxybenzoate-0.01-0.1 g, propyl-4-hydroxybenzoate-0.01-0.1 g, propylene glycol 5-70 g, hydroxyethylcellulose – 1.5-5 g and water - up to 100 g.
EFFECT: creation of a new drug that is effective against pathogens that cause sexually transmitted diseases and is not toxic and irritating.
3 cl, 8 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION FOR TREATING UROGENITAL INFECTIONS | 2008 |
|
RU2401102C2 |
TAMPON FOR WOMEN WITH PROLONGED CURATIVE-PROPHYLACTIC ACTION | 2000 |
|
RU2178312C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING UROGENITAL DISEASES | 2008 |
|
RU2375064C1 |
TREATMENT-AND-PREVENTIVE AGENT OF ANTIBACTERIAL AND SPERMICIDAL ACTION | 2006 |
|
RU2329790C1 |
METHOD FOR COMPLEX TREATMENT OF RECURRENT APHTHOUS STOMATITIS | 2021 |
|
RU2773614C1 |
TREATMENT-AND-PROPHYLACTIC PREPARATION "GEKSIKON" WITH ANTIBACTERIAL AND ANTISEPTIC ACTION | 1999 |
|
RU2166314C2 |
THERAPEUTIC PREPARATION | 2000 |
|
RU2161961C1 |
IMMUNOMODULATING, ANTIVIRAL, ANTIBACTERIAL, ANTIOXIDATING, MEMBRANE STABILISING, ANTI-INFLAMMATORY, ANTITOXIC MEDICINAL AGENT FOR INFLAMMATORY-INFECTIOUS DISEASES | 2007 |
|
RU2327486C1 |
METHOD OF TREATING VULVOVAGINITIS | 2020 |
|
RU2735079C1 |
METHOD FOR TREATING ACNE AT THE BACKGROUND OF UROGENITAL INFECTION AND VAGINAL DYSBIOSIS | 2004 |
|
RU2269944C2 |
Authors
Dates
2017-12-19—Published
2017-04-27—Filed